DICE

Dice Therapeutics Inc

A biopharmaceutical company that developed oral pill treatments for chronic autoimmune and inflammatory diseases such as psoriasis, aiming to offer a convenient alternative to injectable biologic drugs. Founded in 2013, its name "DiCE" stands for Directed Chemical Evolution, reflecting a platform that mimics biology's own trial-and-error evolution to design medicines. In 2023 it was acquired by pharmaceutical giant Eli Lilly.